Luna SAD, Guerrero ÁF

Language: Spanish
References: 17
Page: 194-197
PDF size: 301.30 Kb.

ABSTRACT

Introduction: The interaction of periodontal disease is related to the environment, host, microbial factors and genetic susceptibility. In this condition, the interaction of bacteria and the immune system result in increased production of inflammatory mediators such as IL-1, IL-6 interleukins, and TNF-α that will destroy connective tissue and bone. Diabetes itself either type 1 or 2 will have repercussions at the level of the different organs of the economy as it is kidneys, nervous system, eyes, circulatory system and hence the periodontium. When the patient is not in controlling systemic adverse effects are increased and synergy between periodontal health and glycemic involvement provoked. It has been reported regarding the beneficial effect of periodontal treatment on glycemic control in diabetic and non-diabetic patients. Conclusion: The non-surgical periodontal treatment was shown to reduce the values of periodontal parameters and serum fasting glucose and glycated hemoglobin and assist in glycemic control.

REFERENCES

1. Kinane DF, Peterson M, Stathopoulou PG. Enviromental and other modifying factors of the periodontal diseases. Periodontol. 2000; 2006; 40: 107-119.

2. Chapple IL, Genco R; working group 2 of the joint EFP/AAP workshop. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP workshop on periodontitis and systemic diseases. J Periodontol. 2013; 84 (4 Suppl): S106-112.

3. Taylor G. Periodontal infection and glycemic control in diabetes: current evidence inside dentistry. J Clin Periodontol. 2005; 2: 135-140.

4. Correa S, Rengifo A. Mecanismos moleculares implicados en la destrucción ósea en la periodontitis. Rev Clin Periodoncia Implantol Rehabil Oral. 2013; 6: 142-147.

5. Tervonen T, Karjalainen K, Knuuttila M, Huumonen S. Alveolar bone loss in type 1 diabetic subjects. J Clin Periodontol. 2000; 27: 567-571.

6. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996; 23: 92-100.

7. Rodrigues DC, Taba MJ, Novaes AB, Souza SL, Grisi MF. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol. 2003; 74: 1361-1367.

8. Teixidor JR, Masso JG. Medicina interna volumen II. 2a ed., Editorial Masson, España 2004.

9. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo JH. Principios de Medicina Interna, 18a ed. Edit. McGraw-Hill, España, 2012.

10. American Diabetes Association, Standards of Medical Care in Diabetes 2015. 2015; 38 (Suppl. 1).

11. American Diabetes Association, Standards of Medical Care in Diabetes 2017. 2017; 40 (Suppl. 1).

12. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trend in fasting plasma glucose and diabetes prevalence since 1980: systemic analysis, of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011; 378 (9785): 31-40.

13. Zhang Y, Dall TM, Mann SE, Chen Y, Martin J, Moore V et al. The economic costs of undiagnosed diabetes. Popul Health Manag. 2009; 12 (2): 95-101.

14. Gurav A, Jadhav V. Periodontitis and risk of diabetes mellitus. J Diabetes. 2011; 3: 21-28.

15. Linden GJ, Herzberg MC; working group 4 of the joint EFP/AAP Workshop. Periodontitis and systemic diseases: a record of discussions. J Clin Periodontol. 2013; 40 (Suppl 14): 20-23.

16. Engebestron S, Krocher T. Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis. J Clin Periodontol. 2013; 40 (Suppl 14): S153-163.

17. Taylor GW, Borgnakke WS. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis. 2008; 14: 191-203.